中文版 | English
Title

Different clinical guidelines, common goal: To reduce COVID-19 mortality

Author
Corresponding AuthorLu, Hongzhou
Publication Years
2023
DOI
Source Title
ISSN
1881-7815
EISSN
1881-7823
Abstract
The tendency of the Omicron variant to rapidly became the dominant SARS-CoV-2 strain and its weaker virulence than other strains worldwide has prompted many countries to adjust their public health strategies. This work summarizes all appropriate clinical interventions to reduce the public health burden caused by COVID-19 according to guidelines from the World Health Organization and 10 countries, i.e., the United States of America (USA), India, France, Germany, Brazil, South Korea, Japan, Italy, the United Kingdom (UK), and China. Five stages of COVID-19 were identified: asymptomatic infection and mild, moderate, severe, and critical illness. Most guidelines recommend antivirals starting with mild cases for those from Germany and India. Since more drugs are being developed and are becoming available to COVID-19 patients, guidelines are increasingly being updated with new pharmacological intervention strategies. Thus, a global view needs to be adopted to provide helpful options and precise treatment strategies during the lasting fight against the COVID-19 pandemic.
Keywords
URL[Source Record]
Indexed By
Language
English
SUSTech Authorship
First ; Corresponding
Funding Project
National Natural Science Foundation of China[92169119] ; Shenzhen Municipal Science and Technology Innovation Committee[JCYJ20220531102202005]
WOS Research Area
Life Sciences & Biomedicine - Other Topics
WOS Subject
Biology
WOS Accession No
WOS:000921615000001
Publisher
Data Source
Web of Science
Citation statistics
Cited Times [WOS]:0
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/475018
DepartmentThe Third People's Hospital of Shenzhen
Affiliation
1.Southern Univ Sci & Technol, Peoples Hosp Shenzhen 3, Natl Clin Res Ctr Infect Dis, Shenzhen, Guangdong, Peoples R China
2.Southern Univ Sci & Technol, Hosp Affiliated 2, Shenzhen, Guangdong, Peoples R China
3.Shenzhen Univ, Sch Publ Hlth, Hlth Sci Ctr, Shenzhen, Guangdong, Peoples R China
4.Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis & Immunol, Shanghai, Peoples R China
5.Shenzhen Third Peoples Hosp, Natl Clin Res Ctr Infect Dis, Dept Infect Dis, Shenzhen 518112, Guangdong, Peoples R China
First Author AffilicationThe Third People's Hospital of Shenzhen
Corresponding Author AffilicationThe Third People's Hospital of Shenzhen
First Author's First AffilicationThe Third People's Hospital of Shenzhen
Recommended Citation
GB/T 7714
Sun, Liqin,Liu, Jiaye,Zhao, Fang,et al. Different clinical guidelines, common goal: To reduce COVID-19 mortality[J]. BioScience Trends,2023.
APA
Sun, Liqin,Liu, Jiaye,Zhao, Fang,Chen, Jun,&Lu, Hongzhou.(2023).Different clinical guidelines, common goal: To reduce COVID-19 mortality.BioScience Trends.
MLA
Sun, Liqin,et al."Different clinical guidelines, common goal: To reduce COVID-19 mortality".BioScience Trends (2023).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Sun, Liqin]'s Articles
[Liu, Jiaye]'s Articles
[Zhao, Fang]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[Sun, Liqin]'s Articles
[Liu, Jiaye]'s Articles
[Zhao, Fang]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Sun, Liqin]'s Articles
[Liu, Jiaye]'s Articles
[Zhao, Fang]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.